The study of one hundred and twenty (120) independent participants, showed that total cholesterol (TC), Triglycerides (TG), and high-density cholesterol (HDL) evaluations, for both Venous blood (VB) and capillary blood (CB) specimen samples had 100% accuracy within 15% absolute bias in comparison to laboratory method (Roche Cobas c111) The PixoTest…
Pharma Boardroom for the coverage: Little Fish, Big Pond-Growing a Taiwanese Medtech Startup Internationally
Thank you Pharma Boardroom for the coverage! ” iXensor is devoted to leveraging the power of Point-of-Care (POC) diagnostics to provide a comprehensive mobile health solution across a variety of essential health areas. “We originally started iXensor in glucose management exclusively. However, with our technology platform, we were able to expand…
PixoTest HbA1c POCT System overcame the weakness of current POC HbA1c systems
The latest clinical study, Mobile Health for Diagnosis – PixoTest HbA1c POCT System(1), published in the Journal of Medical and Biological Engineering (JMBE), proved that PixoTest POCT System can be the solution for the dilemma of incorporating both portability and accuracy simultaneously. The study illustrated the following benefits of the…
iXensor is honored to be covered in Pharma Boardroom as a biotech leading company!
It’s a great pleasure to be selected as one of the biotech leading company by Pharma Boardroom to talk about our innovation and vision. We’re grateful for the opportunity to share our thoughts about the combination of ICT and medical field which we’re working on now! See full coverage: https://pharmaboardroom.com/interviews/alan-tsai-general-manager-carson-chen-cto-ixensor-taiwan/
PixoTest Lipid Monitoring System is TFDA certified!
PixoTest Lipid Monitoring System utilizes iXensor’s patented PixoTest technology to analyze Lipid panel tests by lighting and image sensing module of the mobile device to detect the color change reaction on the biochemical test strip.The image of the test strip is captured by the front camera of the smart device…
US FDA Clearance Approval for PixoTest POCT Analyzer and PixoTest A1c Test Kit
iXensor Co., Ltd, is the leading digital mobile health company that developed the PixoTech platform to analyze colorimetric assays using smartphone cameras. iXensor announces that its PixoTest POCT Analyzer and PixoTest A1c Test Kit has received the U.S. Food and Drug Administration 510(k) clearance for clinical laboratory and Point-of-Care. “The…
Merck Accelerator Program Selected! iXensor is Proud To Be One Of The Ten In The World!
iXensor is chosen to be one of the 10 startups who can join the 2019 Merck Accelerator Program. Among 595 application all over the world, iXensor stands out by its innovative PixoTech technology which turns mobile devices into in vitro diagnostic platform. Merck Accelerator Program aims to build sustainable…